NYEE HomeThe New York Eye and Ear Infirmary
Patient InfoHealthcare ProfessionalsSpecialties & ServicesSupport NYEEAbout Us
  Current Research
Clinical Trials in Ophthalmology
Ophthalmology
Research

Otolaryngology
Research

Pathology
& Laboratory Medicine
Research

Plastic &
Reconstructive
Surgery
Research

Institutional
Review Board
(IRB)

 
printer-friendly version of this pagePrinter-Friendly Page large print version of this pageLarge Print Version 

A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vigamox™ in the Treatment of Bacterial Conjunctivitis

Principal Investigator: Lois McNally, MD

Enrollment Status: Open

Objective:  This is a Phase 3 investigational study to evaluate the clinical and microbial efficacy of 0.6% ISV-403 administered TID (three times a day) for 5 days compared to Vigamox™ TID for 5 days in the treatment of bacterial conjunctivitis.

Eligibility:  Contact Principal Investigator/Coordinator

Contact Information:  

  • Principal Investigator: Lois McNally, MD at (212) 979-4077
  • Katy Tai, CR Manager (212) 979-4251

 

Home > Current Research > Clinical Trials in Ophthalmology > A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vigamox™ in the Treatment of Bacterial Conjunctivitis